KISQALI cpr pell 200 mg 63 pce
7680663770026
CH-66377
L01EF02
07.16.1.
Reimbursement limitations:
KISQALI.01
Pour le traitement des femmes pré-, péri- ou postménopausées et des hommes avec un cancer …
1 / 3
google
Details
- Product number
- 6637701
- CPT
- -
- Packaging group
- 63
- Unit
- Tablette(n)
- Composition
- ribociclibum 200 mg ut ribociclibi succinas 254.40 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), talcum, lecithinum, xanthani gummi, E 171, E 172, pro compresso obducto.
Articles (1)
Kisqali 200 mg, Filmtabletten
Filmtabletten
63
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
254.4 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 2383.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2019
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66377
- Drug name
- Kisqali, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EF02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/10/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KISQALI cpr pell 200 mg 63 pce
- Description (DE)
- KISQALI Filmtabl 200 mg 63 Stk
- Market launch
- 24/10/2017
- Narcotic (BTM)
- No